Cocrystal Pharma, Inc. ( COCP) - Key Metrics
COCP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.23 | -$0.18 | -$0.18 |
| 2026Q1 | $0.02 | -$0.17 | -$0.17 | -$0.17 |
| 2025Q4 | $0 | -$0.21 | -$0.15 | -$0.15 |
| 2025Q3 | $0 | -$0.19 | -$0.14 | -$0.14 |
| 2025Q2 | $0 | -$0.20 | -$0.21 | -$0.21 |
COCP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.14 |
| 2026Q1 | 0% | -1.49 |
| 2025Q4 | 0% | -1.36 |
| 2025Q3 | 0% | -1.64 |
| 2025Q2 | 0% | -1.86 |
COCP
Price: $1.07
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 92200
Market Capitalization: 15.3 million